Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage
NCT03578263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2020-08-05
Summary
The cesarean section is a bloody operation, about 750 to 1000 ml are lost at most operations and over 1000 ml of blood have lost to bring them into the definition of a postpartum hemorrhage (PPH). In developing countries, PPH is the main cause of maternal deaths. Uterine atony is the most common cause of immediate heavy PPH.Multiple pregnancy ones of a common factor for uterine atony. The administration of oxytocic's after the delivery of the neonate reduces the likelihood of PPH and 5 IU oxytocin by slow intravenous injection is currently recommended for all cesarean sections. However, the use of additional oxytocic medication is common, to arrest bleeding, or prophylactically if there are risk factors for PPH . Carbetocin is a synthetic analog of human oxytocin with structural modifications that increase its half-life, thereby prolonging its pharmacological effects. Carbetocin has been approved in 23 countries for prevention of uterine atony and excessive bleeding following cesarean delivery in spinal or epidural anesthesia. Oxytocin is a peptide of nine amino acids (Nona peptide). The structure of oxytocin is very similar to that of arginine vasopressin, whose sequence differs from oxytocin by 2 amino acids. The best-known mechanism for oxytocin to exert its stimulatory effect on myometrial contractility is by increasing the intracellular concentration of calcium. Owing to its short plasma half-life (mean 3 min), a continuous intravenous infusion is required to maintain the uterus in a contracted state. The usual dose is 20 IU in 500 ml of crystalloid solution, with the dosage rate adjusted according to response. Ergometrine is a selective and moderately potent tryptaminergic receptor antagonist in various smooth muscles, being only a partially agonistic or antagonistic at tryptaminergic receptors in the central nervous system. In blood vessels, the alkaloid is only weakly antagonistic of dopaminergic receptors and partially agonistic of α-adrenergic receptors. oxytocin (19%). Blood loss\>500 ml was only observed in women who received oxytocin. The aim of the investigator's study was to compare the effect of carbetocin vs. oxytocin and ergometrine for prevention of PPH during cesarean section in women with multiple pregnancies.
Conditions
- Cesarean Section Complications
Interventions
- DRUG
-
Carbetocin
Group (A): included 100 patients who received carbetocin 100 µg diluted in 10 ml normal saline and administered slowly (over 30-60 seconds) intravenously by anesthetist after the birth of the baby.
- DRUG
-
oxytocin
Group (B): included 100 patients who received a combination of intraoperative oxytocin 5 I.U which was diluted in 10 ml normal saline and administered slowly over (30-60 seconds) intravenously by anesthetist and
- DRUG
-
ergometrine
intramuscular ergometrine 0.2 mg.
Sponsors & Collaborators
-
Aswan University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2020-03-31
- Completion
- 2020-08-01
Countries
- Egypt
Study Locations
More Related Trials
-
Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage
NCT02396303 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain
NCT02642263 ·Status: UNKNOWN ·Phase: PHASE4
-
Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage
NCT04300452 ·Status: UNKNOWN ·Phase: PHASE4
-
Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH
NCT04089176 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Carbetocin Compared To Oxytocin During Cesarean Delivery
NCT05758012 ·Status: UNKNOWN
-
Comparison Of The Effects Of Carbetocin And Oxytocin In C-Sectıon
NCT05742854 ·Status: UNKNOWN ·Phase: PHASE4
-
Carbetocin in the Prevention of Primary Postpartum Haemorrhage
NCT06159959 ·Status: COMPLETED
-
Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section
NCT03777878 ·Status: UNKNOWN ·Phase: NA
-
Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section
NCT05083910 ·Status: COMPLETED ·Phase: NA
-
Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections
NCT03651882 ·Status: COMPLETED ·Phase: PHASE4
-
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
NCT03693599 ·Status: COMPLETED ·Phase: PHASE4
-
Haemodynamic Effects of Oxytocin and Carbetocin
NCT01277978 ·Status: COMPLETED
-
Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?
NCT00257803 ·Status: COMPLETED ·Phase: NA
-
Uterotonics Using to Reduce Bleeding at Cesarean Section
NCT02562300 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women
NCT06217354 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections
NCT03939806 ·Status: UNKNOWN
-
The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)
NCT02053922 ·Status: COMPLETED ·Phase: PHASE3
-
Carbetocin Versus Oxytocin and Hemodynamic Effects
NCT00977769 ·Status: COMPLETED ·Phase: PHASE4
-
Outcomes After the Implementation of a New Oxytocin Protocol
NCT02722356 ·Status: COMPLETED ·Phase: NA
-
Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2
NCT03957083 ·Status: COMPLETED ·Phase: NA
-
Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery
NCT03959436 ·Status: COMPLETED
-
Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium
NCT03852797 ·Status: COMPLETED ·Phase: NA
-
Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline)
NCT05273632 ·Status: COMPLETED ·Phase: NA
-
Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN
NCT02221531 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section
NCT02046499 ·Status: COMPLETED ·Phase: NA